Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Could MannKind Corporation Be Running Out of Money?
NASDAQ.com
Tuesday, October 28, 2014 - 9:43am
tags:
MannKind
Ackman’s $5.3 Billion Allergan Bet Examined Before Vote
Bloomberg
Tuesday, October 28, 2014 - 8:58am
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A
Sanofi shares plunge after diabetes drug warning
Yahoo/AP
Tuesday, October 28, 2014 - 8:57am
tags:
Sanofi, diabetes, Lantus
Ranbaxy books first profit in six quarters on exclusive drug launch
Reuters
Tuesday, October 28, 2014 - 8:51am
tags:
Ranbaxy, earnings
Four Biotechs Lead Health Care Stocks In Big Cap 20
Investors.com
Tuesday, October 28, 2014 - 8:44am
tags:
Alexion, Amgen, Celgene, Regeneron
Novartis Third-Quarter Profit Climbs on New Products
Bloomberg
Tuesday, October 28, 2014 - 8:34am
tags:
Novartis, earnings
Pfizer beats sales and profit forecasts, mum on future deals
Yahoo/Reuters
Tuesday, October 28, 2014 - 8:28am
tags:
Pfizer, earnings
Amgen profit tops Wall Street expectations; raises 2014 outlook
Yahoo/Reuters
Monday, October 27, 2014 - 5:46pm
tags:
Amgen, earnings
U.S. judge pares $9 bln award against Takeda, Eli Lilly over drug
Yahoo/Reuters
Monday, October 27, 2014 - 5:26pm
tags:
Takeda, Eli Lilly, Actos, diabetes
Gilead Rises Ahead Of Q3 Earnings As Rivals Wobble
Investors.com
Monday, October 27, 2014 - 5:24pm
tags:
Gilead Sciences, earnings
Dealpolitik: Path to Nowhere in Allergan Litigation?
WSJ Online
Monday, October 27, 2014 - 3:29pm
tags:
Allergan, M&A, Valeant Pharmaceuticals
Will Novartis (NVS) Disappoint in Q3 Earnings Season?
Yahoo/Zacks.com
Monday, October 27, 2014 - 3:26pm
tags:
Novartis, earnings
If It’s Bad For Merck, It’s Good For Gilead
Barron's
Monday, October 27, 2014 - 3:25pm
tags:
Merck, Gilead Sciences, hepatitis C, Sovaldi, JNJ, Olysio
Breakthrough Pathway: Lone Bright Spot Among the Macro Trends for Medical Devices?
Morning Consult
Monday, October 27, 2014 - 10:53am
tags:
devices, breakthrough pathway, innovation, FDA, CMS
Aegerion, Seattle Genetics CEOs Accused in Suit of Cocaine Use
TheStreet.com
Monday, October 27, 2014 - 10:50am
tags:
Aegerion, Seattle Genetics, Pharma CEOs
Pfizer finally abandons all hope in Remoxy, and Pain Therapeutics feels the sting
Fierce Biotech
Monday, October 27, 2014 - 9:44am
tags:
Pfizer, Remoxy, Pain Therapeutics
Allergan Comments on Valeant's Potential Increased Offer
Yahoo
Monday, October 27, 2014 - 9:28am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Merck grabs another 'breakthrough' in PD-1 lung cancer race with Bristol-Myers
Fierce Biotech
Monday, October 27, 2014 - 9:09am
tags:
Merck, Bristol-Myers Squibb, anti-PD-1 immunotherapy, lung cancer, Keytruda
Pfizer To Report Lower Earnings and Revenue For Q3FY14
Bidness Etc.
Monday, October 27, 2014 - 9:04am
tags:
Pfizer, earnings
Sarepta timeline delayed on muscular dystrophy drug
CNBC
Monday, October 27, 2014 - 8:51am
tags:
Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.